跳至主要内容
临床试验/NCT01340612
NCT01340612已完成不适用

Stenting in the Treatment of Large, Wide-necked or Recurring Intracranial Aneurysms

Centre hospitalier de l'Université de Montréal (CHUM)7 个研究点 分布在 2 个国家目标入组 205 人开始时间: 2011年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
205
试验地点
7
主要终点
Recurrence rate of target aneurysm

研究概览

简要总结

The STAT trial aims at comparing coiling versus coiling plus stenting in patients with aneurysms prone to recurrence, that is large aneurysms or recurring aneurysms after previous coiling or wide-necked aneurysms. The primary hypothesis is that the use of stenting in addition to coiling decreases the recurrence rate from 33% to 20% at 12 months as compared to coiling alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients presenting at least one aneurysm candidate for coiling, with large (≥10mm), wide-necked (>4mm), or recurrent lesions after coiling (but not stenting) and judged by the neurovascular team to require elective treatment provided that this single lesion, and no other aneurysm, will be treated during the endovascular session to be the object of the trial
  • The anatomy of the lesion is such that endovascular treatment is judged possible with or without stenting
  • The endovascular physician is a priori content to use either type of technique
  • The patient has not previously been randomized into the trial
  • Treatment is elective
  • Patient is 18 or older
  • Life expectancy is more than 2 years
  • Patient has given fully informed consent and has signed consent form

排除标准

  • Other aneurysms requiring treatment during the same session
  • Patients with associated cerebral arteriovenous malformations
  • Patients with recently ruptured aneurysms
  • When parent vessel occlusion is the primary intent of the procedure
  • Any absolute contraindication to endovascular treatment, angiography, or anesthesia such as severe allergies to contrast or medications, including ASA and Clopidogrel
  • Patients with recurring, previously stented aneurysms

结局指标

主要结局

Recurrence rate of target aneurysm

时间窗: 12 months

rate of angiographic recurrence

次要结局

  • Rate of Procedural complications defined as number of subjects with reported peri-procedural Adverse Events(30 days)
  • Incidence of in-stent stenosis defined as the number of subjects with a reduction in the luminal diameter of greater than 50%(12 months)
  • Overall morbidity and mortality given by the modified Rankin Score(12 months)
  • Rate of mortality and morbidity defined as the number of subjects with a disabling neurological events as measured by a modified Rankin Score greater than 2 during the follow-up period(12 months)

研究者

发起方
Centre hospitalier de l'Université de Montréal (CHUM)
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验